ST. CHARLES MED CTR - PRINEVILLE — History
CCN 381313 | 3-year financial timeline | COVID resilience: 83/100
🛡️ Public data only — no PHI permitted on this instance.
$62M
Latest Revenue (FY2022)
+24.2%
Revenue CAGR (3yr)
24.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $40M | $51M | $62M | +22.9% | +24.2% |
| Operating Expenses | $35M | $41M | $47M | +14.7% | +15.5% |
| Operating Margin | 12.8% | 19.2% | 24.6% | +28.3% | +38.8% |
| Net Income | $5M | $10M | $15M | +57.7% | +72.4% |
| Licensed Beds | 16 | 16 | 16 | +0.0% | +0.0% |
| Total Patient Days | 3,037 | 3,776 | 3,159 | -16.3% | +2.0% |
| Medicare Day % | 55% | 51% | 46% | -10.8% | -8.6% |
| Medicaid Day % | 3% | 2% | 1% | -66.1% | -54.5% |
COVID Impact & Recovery
Resilience Score: 83/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +54.4% ($40M → $62M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+24.2%
This Hospital
+7.6%
State Avg
Latest Margin
24.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $73M | 30.6% |
| FY2024 (proj) | $84M | 36.5% |
| FY2025 (proj) | $95M | 42.4% |